Contact this trialFirst, we need to learn more about you.
Cytotoxic Agent
Immunotherapy + Chemotherapy for High-Risk Neuroblastoma
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial is testing a combination of immunotherapy and chemotherapy in patients with high-risk neuroblastoma to see if it is more effective than chemotherapy alone.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.